Status:
COMPLETED
The Importance of Wnt-signaling After Cardiac Surgery
Lead Sponsor:
Alain Rudiger
Collaborating Sponsors:
University of Zurich
Conditions:
Inflammation
Thoracic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Cardiac surgery saves lives when patients suffer from cardiac disease. Local inflammation is important for tissue repair and wound healing after such an operation. Inflammation starts already when the...
Detailed Description
The aim of this project is to understand early inflammation mechanisms after cardiac surgery. Therefore, repeated blood samples of patients undergoing cardiac surgery will be taken. Patients are selec...
Eligibility Criteria
Inclusion
- Cardiac surgery via sternotomy
- Coronary-bypass bypass surgery with or without valve surgery
- Postoperative hospitalisation in the cardio-surgical ICU
- Available informed consent
Exclusion
- Preoperative infections (e.g. endocarditis)
- Preoperative use of steroids or other immunosuppression
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04058496
Start Date
November 1 2018
End Date
April 1 2022
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Zurich, Switzerland